Concurrently, Fitch affirmed its “AA-/ F1+” rating on MHS’ outstanding debt, affecting $429 million of debt. The short-term rating is based on the health system’s self-liquidity.
The long-term rating affirmation and assignment is a result of MHS’ strong financial profile, reflected by its favorable leverage metrics and sufficient cash flow generation. Fitch also acknowledged the health system’s highly competitive market and weaker profitability as a result of the competitive market.
The outlook is stable.
More articles on healthcare finance:
Moody’s: Nonprofit hospital rating downgrades rose sharply in 2017
Disney pledges $100M to enhance the patient experience at children’s hospitals
University Medical Center operator threatens to terminate management agreement over budget impasse
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
